Stryker Corp
SYKHealthcare·Medical Devices·USA·Large·NYSE·Nov 11 • 4:00 PM ET
318.79-5.50 (-1.70%)
2026-11-12 05:37 CET
Market cap
121,360.48 USD m
Revenue, TTM
26,300.00 USD m
Net income, TTM
3,623.00 USD m
Free cash flow, TTM
4,573.00 USD m
EPS diluted, TTM
9.39
P/E
33.96
Price
SYK against its 20, 50 and 200-day averages2050200beatmiss
18.1% under the 52-week high of 389.33 on 2 Mar 2026. 52-week low 267.00 on 11 Sep 2026. Last 15 sessions, 23.9% high to low
Volume 1.13× normal · the line is the 50-bar volume average
Profile
SYK52-week range, 42% of the way up
267389.33
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
| Index | S&P 500, RUI |
|---|---|
| Employees | 56000 |
| IPO | Mar 17, 1980 |
| Beta | 0.76 |
| ATR, 14d | 11.18 |
| Rel volume | 1.13 |
| Short float | 1.86% |
| Insider own | 5.88% |
| Inst own | 83.24% |
Snapshot
6 groupsValuation
| Index | S&P 500, RUI |
|---|---|
| Market Cap | 121.36B |
| Enterprise Value | 133.52B |
| Income | 3.62B |
| Sales | 26.30B |
| Book/sh | 61.62 |
| Cash/sh | 8.59 |
| Dividend Est. | 3.53 (1.11%) |
| Dividend TTM | 3.52 (1.10%) |
| Dividend Ex-Date | Sep 30, 2026 |
| Dividend Gr. 3/5Y | 6.31% 7.67% |
| Payout | 40.48% |
| Employees | 56000 |
| IPO | Mar 17, 1980 |
Ratios
| P/E | 33.96 |
|---|---|
| Forward P/E | 19.55 |
| PEG | 1.97 |
| P/S | 4.61 |
| P/B | 5.17 |
| P/C | 37.10 |
| P/FCF | 26.54 |
| EV/EBITDA | 17.42 |
| EV/Sales | 5.08 |
| Quick Ratio | 1.30 |
| Current Ratio | 2.18 |
| Debt/Eq | 0.66 |
| LT Debt/Eq | 0.62 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 9.39 |
|---|---|
| EPS next Y | 16.31 |
| EPS next Q | 5.03 |
| EPS this Y | 8.85% |
| EPS next Y | 9.91% |
| EPS next 5Y | 9.90% |
| EPS past 3/5Y | 10.83% 14.84% |
| Sales past 3/5Y | 10.83% 11.84% |
| EPS Y/Y TTM | 22.82% |
| Sales Y/Y TTM | 7.87% |
| EPS Q/Q | -11.88% |
| Sales Q/Q | 7.64% |
| Earnings | Oct 29 AMC |
| EPS/Sales Surpr. | -0.79% -1.47% |
Ownership
| Insider Own | 5.88% |
|---|---|
| Insider Trans | -5.19% |
| Inst Own | 83.24% |
| Inst Trans | 1.16% |
| ROA | 7.68% |
| ROE | 16.02% |
| ROIC | 9.54% |
| Gross Margin | 63.21% |
| Oper. Margin | 24.56% |
| Profit Margin | 13.78% |
| SMA20 | 2.77% |
| SMA50 | 9.10% |
| SMA200 | -1.11% |
| Trades | - |
Technical
| Shs Outstand | 380.70M |
|---|---|
| Shs Float | 358.30M |
| Short Float | 1.86% |
| Short Ratio | 2.34 |
| Short Interest | 6.66M |
| 52W High | 389.33 -18.12% |
| 52W Low | 267.00 19.40% |
| Volatility | 2.65% 3.03% |
| ATR (14) | 11.18 |
| RSI (14) | 56.57 |
| Beta | 0.76 |
| Rel Volume | 1.13 |
| Avg Volume | 2.85M |
| Volume | 3,215,580 |
Performance
| Perf Week | -6.14% |
|---|---|
| Perf Month | 12.83% |
| Perf Quarter | -6.54% |
| Perf Half Y | 5.53% |
| Perf YTD | -9.30% |
| Perf Year | -12.35% |
| Perf 3Y | 16.51% |
| Perf 5Y | 21.02% |
| Perf 10Y | 188.86% |
| Recom | 1.71 |
| Target Price | 340.68 |
| Prev Close | 324.29 |
| Price | 318.79 |
| Change % | -1.70% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 30, 2026 | Downgrade | CCanaccord Genuity | Buy → Hold | $300 | -5.9% |
| Oct 07, 2026 | Initiated | BBarclays | Overweight | $375 | +17.6% |
| Aug 13, 2026 | Downgrade | WWolfe Research | Outperform → Peer Perform | ||
| Jul 28, 2026 | Resumed | UUBS | Buy | $400 | +25.5% |
| Jul 09, 2026 | Initiated | BBMO Capital Markets | Outperform | $369 | +15.8% |
| Apr 13, 2026 | Initiated | LLeerink Partners | Outperform | $410 | +28.6% |
| Feb 20, 2026 | Initiated | WWilliam Blair | Outperform | ||
| Jan 27, 2026 | Resumed | TTD Cowen | Hold | $387 | +21.4% |
| Jan 06, 2026 | Upgrade | RRaymond James | Mkt Perform → Outperform | $418 | +31.1% |
| Dec 19, 2025 | Upgrade | CCitizens JMP | Mkt Perform → Mkt Outperform | $440 | +38.0% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| ZBH | Zimmer Biomet Holdings Inc | 20.34B |
| MDT | Medtronic Plc | 129.98B |
| SNN | Smith & Nephew plc ADR | 12.99B |
| BSX | Boston Scientific Corp | 65.41B |
| ISRG | Intuitive Surgical Inc | 155.83B |
| ABT | Abbott Laboratories | 189.28B |
| EW | Edwards Lifesciences Corp | 60.84B |
| BDX | Becton Dickinson & Co | 58.43B |
| BAX | Baxter International Inc | 13.63B |
| TFX | Teleflex Incorporated | 6.20B |
Insider trading
latest 14 of 37| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director | Nov 06 '26 | Sale | 325.32 | 550,000 | 178,924,731 | 1,701,375 | Nov 09 04:29 PM |
| STRYKER RONDA E | Director | Nov 06 '26 | Proposed Sale | 339.65 | 550,000 | 186,807,500 | Nov 05 04:41 PM | |
| Crotty Dylan Bram | Group President | Aug 21 '26 | Sale | 328.61 | 441 | 144,915 | 6,102 | Aug 26 04:33 PM |
| STRYKER RONDA E | Director | Aug 18 '26 | Sale | 335.90 | 300,000 | 100,770,963 | 2,301,375 | Aug 20 05:12 PM |
| STRYKER RONDA E | Director | Aug 19 '26 | Sale | 340.10 | 50,000 | 17,005,165 | 2,251,375 | Aug 20 05:12 PM |
| King Debra | See Remarks | Aug 18 '26 | Sale | 336.30 | 826 | 277,787 | 6,210 | Aug 18 04:34 PM |
| Debra King | Officer | Aug 18 '26 | Proposed Sale | 336.30 | 826 | 277,786 | Aug 18 12:44 PM | |
| STRYKER RONDA E | Director | Aug 18 '26 | Proposed Sale | 335.00 | 350,000 | 117,250,000 | Aug 17 10:13 AM | |
| Fletcher Robert S | VP, Chief Legal Officer | May 28 '26 | Sale | 306.87 | 4,544 | 1,394,409 | 10,582 | May 29 04:59 PM |
| STRYKER RONDA E | Director | May 26 '26 | Sale | 312.23 | 310,000 | 96,792,669 | 1,924,880 | May 28 05:22 PM |
| Fletcher Robert S | Officer | May 28 '26 | Proposed Sale | 305.59 | 4,544 | 1,388,601 | May 28 04:48 PM | |
| STRYKER RONDA E | Director | May 26 '26 | Proposed Sale | 313.00 | 310,000 | 97,030,000 | May 27 08:49 AM | |
| Fink M Kathryn | VP, Chief HR Officer | May 08 '26 | Option Exercise | 167.98 | 21,582 | 3,625,388 | 34,719 | May 12 04:37 PM |
| Fink M Kathryn | VP, Chief HR Officer | May 11 '26 | Sale | 283.85 | 5,220 | 1,481,671 | 13,137 | May 12 04:37 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| VOO | Vanguard S&P 500 ETF | AUM: 1054.75B |
| IVV | iShares Core S&P 500 ETF | AUM: 871.38B |
| SPY | SPDR S&P 500 ETF Trust | AUM: 793.23B |
| VTV | Vanguard Morningstar Value ETF | AUM: 196.23B |
| XLV | State Street Health Care Select Sector SPDR ETF | AUM: 50.35B |
| VIG | Vanguard Dividend Appreciation FTF | AUM: 117.07B |
| SPYM | State Street SPDR Portfolio S&P 500 ETF | AUM: 183.48B |
| JEPI | JPMorgan Equity Premium Income ETF | AUM: 46.80B |
| VHT | Vanguard Health Care ETF | AUM: 21.51B |
News
latest 14 of 200- Stryker announces intention to nominate Jim Davis to board of directors (GlobeNewswire)
- What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street (PR Newswire)
- Zimmer raises sales forecast despite slower knee business (MedTech Dive) +9.37%
- Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS (PR Newswire) -6.38%
- Stryker lowers 2026 guidance after slowdown in hip, knee procedures (MedTech Dive)
- Stryker Misses And Cuts Guidance As Hip And Knee Slowdown Overwhelms Margin Strength (Earnings Whispers)
- Stryker: Q3 Earnings Snapshot (Associated Press)
- Stryker reports third quarter 2026 operating results (GlobeNewswire)
- Stryker completes ZuriMED takeover (MedTech Dive)
- Stryker to participate in the 2026 Jefferies Global Healthcare Conference (GlobeNewswire)
- Overheard in Boston: Medtech CEOs talk rising costs, turbulent markets, cyberattacks (MedTech Dive)
- Stryker completes acquisition of ZuriMED to enhance its shoulder offering (GlobeNewswire)
- Laboratory operator Quest reports cyber breach affecting patient records (Reuters)
- Stryker's Second-Half Ramp Faces Its First Real Test As Vascular Supply Fix Comes Due (Earnings Whispers)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-10-29 | 3.520 | 3.548 | 1.960 | 6,520 | 6,617 | 26 |
| 2026Q2 | 2026-07-30 | 3.690 | 3.488 | 3.306 | 6,589 | 6,579 | 24 |
| 2026Q1 | 2026-04-30 | 2.600 | 2.981 | 1.928 | 6,020 | 6,337 | 26 |
| 2025Q4 | 2026-01-29 | 4.470 | 4.396 | 2.197 | 7,171 | 7,125 | 26 |
| 2025Q3 | 2025-10-30 | 3.190 | 3.133 | 2.221 | 6,057 | 6,045 | 25 |
| 2025Q2 | 2025-07-31 | 3.130 | 3.069 | 2.288 | 6,022 | 5,936 | 27 |
| 2025Q1 | 2025-05-01 | 2.840 | 2.714 | 1.693 | 5,866 | 5,691 | 26 |
| 2024Q4 | 2025-01-28 | 4.010 | 3.872 | 1.414 | 6,436 | 6,361 | 27 |
| 2024Q3 | 2024-10-29 | 2.870 | 2.772 | 2.163 | 5,494 | 5,373 | 28 |
| 2024Q2 | 2024-07-30 | 2.810 | 2.792 | 2.141 | 5,422 | 5,405 | 27 |
| 2024Q1 | 2024-04-30 | 2.500 | 2.356 | 2.046 | 5,243 | 5,105 | 26 |
| 2023Q4 | 2024-01-30 | 3.460 | 3.269 | 2.977 | 5,815 | 5,602 | 26 |
| 2023Q3 | 2023-11-02 | 2.460 | 2.435 | 1.802 | 4,909 | 4,865 | 26 |
| 2023Q2 | 2023-08-03 | 2.540 | 2.381 | 1.922 | 4,996 | 4,826 | 25 |
| 2023Q1 | 2023-05-01 | 2.140 | 2.002 | 1.545 | 4,778 | 4,566 | 25 |
| 2022Q4 | 2023-01-31 | 3.000 | 2.836 | 1.473 | 5,202 | 4,964 | 26 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 8.260 | 8.229 | 5.483 | 14,884 | 14,860 |
| 2020FY | 7.430 | 7.184 | 4.205 | 14,351 | 14,418 |
| 2021FY | 9.090 | 9.109 | 5.216 | 17,108 | 17,059 |
| 2022FY | 9.340 | 9.175 | 6.170 | 18,449 | 18,208 |
| 2023FY | 10.600 | 10.410 | 8.249 | 20,498 | 20,285 |
| 2024FY | 12.190 | 12.054 | 7.762 | 22,595 | 22,523 |
| 2025FY | 13.630 | 13.564 | 8.400 | 25,116 | 25,066 |
| 2026FY | - | 14.836 | - | - | 26,816 |
| 2027FY | - | 16.306 | - | - | 28,705 |
| 2028FY | - | 18.094 | - | - | 30,850 |
| 2029FY | - | 19.773 | - | - | 33,026 |
| 2030FY | - | 21.651 | - | - | 35,324 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-06 | 25 | 0 | 24 | 7,697 | 7,572 | 7,942 |
| 2026Q4 | S | 2026-11-02 | 25 | 0 | 24 | 7,697 | 7,572 | 7,942 |
| 2026Q4 | S | 2026-10-30 | 25 | 0 | 23 | 7,706 | 7,572 | 7,960 |
| 2026Q4 | S | 2026-10-29 | 25 | 1 | 4 | 7,958 | 7,854 | 8,045 |
| 2026Q4 | S | 2026-10-23 | 25 | 1 | 4 | 7,958 | 7,854 | 8,045 |
| 2026Q4 | S | 2026-10-14 | 25 | 1 | 4 | 7,958 | 7,854 | 8,045 |
| 2026Q4 | S | 2026-10-09 | 24 | 6 | 4 | 7,962 | 7,902 | 8,045 |
| 2026Q4 | S | 2026-10-08 | 24 | 7 | 4 | 7,968 | 7,902 | 8,084 |
| 2026Q4 | S | 2026-10-06 | 24 | 7 | 4 | 7,971 | 7,902 | 8,084 |
| 2026Q4 | S | 2026-10-05 | 23 | 7 | 3 | 7,974 | 7,902 | 8,084 |
| 2026Q4 | S | 2026-09-30 | 23 | 7 | 3 | 7,976 | 7,902 | 8,084 |
| 2026Q4 | S | 2026-09-28 | 23 | 7 | 3 | 7,977 | 7,902 | 8,084 |
| 2026Q4 | S | 2026-09-24 | 23 | 7 | 3 | 7,978 | 7,902 | 8,084 |
| 2026Q4 | S | 2026-09-21 | 23 | 6 | 4 | 7,974 | 7,841 | 8,084 |
Estimate history
| EPS, annual | 2.68 | 9.34 | 5.483 | 4.205 | 5.216 | 6.17 | 8.249 | 7.762 | 8.398 | 9.3873 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 2.163 | 1.414 | 1.693 | 2.288 | 2.221 | 2.197 | 1.928 | 3.306 | 1.957 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 12444 | 13601 | 14884 | 14351 | 17108 | 18449 | 20498 | 22595 | 25116 | 26300 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 5494 | 6436 | 5866 | 6022 | 6057 | 7171 | 6020 | 6589 | 6520 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 374.4 | 374.4 | 374.5 | 376.1 | 377.5 | 378.7 | 380.1 | 381.4 | 382.5 | 380.7 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 381.2 | 381.4 | 382.1 | 382.3 | 382.4 | 382.5 | 383.4 | 383.573 | 380.7 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 26,300.00 | 25,116.00 | 22,595.00 | 20,498.00 | 18,449.00 | 17,108.00 | 14,351.00 | 14,884.00 | 13,601.00 |
| Cost of Goods Sold Incl. D&A | 9,675.00 | 9,387.00 | 8,553.00 | 7,926.00 | 7,363.00 | 6,399.00 | 5,598.00 | 5,502.00 | 5,001.00 |
| Gross Profit | 16,625.00 | 15,729.00 | 14,042.00 | 12,572.00 | 11,086.00 | 10,709.00 | 8,753.00 | 9,382.00 | 8,600.00 |
| Selling, General and Administrative Excl. Other | 10,167.00 | 9,883.00 | 8,919.00 | 8,213.00 | 7,306.00 | 6,946.00 | 5,725.00 | 5,994.00 | 5,496.00 |
| Research and Development | 1,625.00 | 1,567.00 | 1,414.00 | 1,293.00 | 1,230.00 | 1,133.00 | 905.00 | 971.00 | 862.00 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 6,458.00 | 5,846.00 | 5,123.00 | 4,359.00 | 3,780.00 | 3,763.00 | 3,028.00 | 3,388.00 | 3,104.00 |
| Interest Expense | 586.00 | 607.00 | 396.00 | 356.00 | 337.00 | 337.00 | 315.00 | 287.00 | 264.00 |
| Unusual Expense | 1,051.00 | 907.00 | 1,359.00 | 412.00 | 899.00 | 1,166.00 | 785.00 | 666.00 | 566.00 |
| Net Income Before Taxes | 5,116.00 | 4,514.00 | 3,492.00 | 3,673.00 | 2,683.00 | 2,281.00 | 1,954.00 | 2,562.00 | 2,356.00 |
| Income Taxes | 1,493.00 | 1,268.00 | 499.00 | 508.00 | 325.00 | 287.00 | 355.00 | 479.00 | -1,197.00 |
| Consolidated Net Income | 3,623.00 | 3,246.00 | 2,993.00 | 3,165.00 | 2,358.00 | 1,994.00 | 1,599.00 | 2,083.00 | 3,553.00 |
| Net Income From Continuing Operations | 3,623.00 | 3,246.00 | 2,993.00 | 3,165.00 | 2,358.00 | 1,994.00 | 1,599.00 | 2,083.00 | 3,553.00 |
| Net Income | 3,623.00 | 3,246.00 | 2,993.00 | 3,165.00 | 2,358.00 | 1,994.00 | 1,599.00 | 2,083.00 | 3,553.00 |
| EPS (Recurring) | 11.33 | 10.04 | 10.23 | 9.00 | 7.82 | 7.35 | 5.65 | 6.71 | 10.38 |
| EPS (Basic, Before Extraordinaries) | 9.46 | 8.49 | 7.86 | 8.34 | 6.23 | 5.29 | 4.26 | 5.57 | 9.50 |
| EPS (Diluted) | 9.39 | 8.40 | 7.76 | 8.25 | 6.17 | 5.22 | 4.20 | 5.48 | 9.34 |
| EBITDA | 7,665.00 | 7,039.00 | 6,173.00 | 5,387.00 | 4,778.00 | 4,753.00 | 3,840.00 | 4,166.00 | 3,827.00 |
| Non-Operating Income (Expense) | 295.00 | 182.00 | 124.00 | 82.00 | 139.00 | 21.00 | 26.00 | 127.00 | 82.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 202.24 | 191.97 | 180.91 | 161.95 | 132.72 | 124.83 | 103.66 | 92.71 | 94.01 |
| Price To Earnings Ratio | 33.96 | 33.96 | 38.60 | 44.42 | 38.04 | 51.29 | 58.34 | 38.28 | 16.78 |
| Price To Sales Ratio | 4.03 | 5.41 | 6.14 | 5.61 | 5.06 | 5.98 | 6.49 | 5.36 | 4.38 |
| Gross Margin | 63.21 | 62.63 | 62.15 | 61.33 | 60.09 | 62.60 | 60.99 | 63.03 | 63.23 |
| Operating Margin | 24.56 | 23.28 | 22.67 | 21.27 | 20.49 | 22.00 | 21.10 | 22.76 | 22.82 |
| Net Margin | 13.78 | 12.92 | 13.25 | 15.44 | 12.78 | 11.66 | 11.14 | 13.99 | 26.12 |
| Shares Outstanding | 380.70 | 382.50 | 381.40 | 380.10 | 378.70 | 377.50 | 376.10 | 374.50 | 374.40 |
| Market Capitalization | 121,360.48 | 121,360.48 | 137,256.82 | 113,776.23 | 92,522.35 | 100,881.52 | 92,083.83 | 78,601.54 | 58,653.81 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,520.00 | 6,589.00 | 6,020.00 | 7,171.00 | 6,057.00 | 6,022.00 | 5,866.00 | 6,436.00 |
| Cost of Goods Sold Incl. D&A | 2,417.00 | 2,231.00 | 2,360.00 | 2,667.00 | 2,310.00 | 2,272.00 | 2,186.00 | 2,329.00 |
| Gross Profit | 4,103.00 | 4,358.00 | 3,660.00 | 4,504.00 | 3,747.00 | 3,750.00 | 3,680.00 | 4,107.00 |
| Selling, General and Administrative Excl. Other | 2,552.00 | 2,544.00 | 2,556.00 | 2,515.00 | 2,383.00 | 2,389.00 | 2,501.00 | 2,326.00 |
| Research and Development | 417.00 | 424.00 | 404.00 | 380.00 | 398.00 | 396.00 | 393.00 | 342.00 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 1,551.00 | 1,814.00 | 1,104.00 | 1,989.00 | 1,364.00 | 1,361.00 | 1,179.00 | 1,781.00 |
| Interest Expense | 143.00 | 141.00 | 148.00 | 154.00 | 157.00 | 159.00 | - | - |
| Unusual Expense | 564.00 | 148.00 | 159.00 | 180.00 | 225.00 | 231.00 | 318.00 | 1,182.00 |
| Net Income Before Taxes | 997.00 | 1,564.00 | 850.00 | 1,705.00 | 1,029.00 | 1,016.00 | 764.00 | 528.00 |
| Income Taxes | 244.00 | 288.00 | 105.00 | 856.00 | 170.00 | 132.00 | 110.00 | -18.00 |
| Consolidated Net Income | 753.00 | 1,276.00 | 745.00 | 849.00 | 859.00 | 884.00 | 654.00 | 546.00 |
| Net Income From Continuing Operations | 753.00 | 1,276.00 | 745.00 | 849.00 | 859.00 | 884.00 | 654.00 | 546.00 |
| Net Income | 753.00 | 1,276.00 | 745.00 | 849.00 | 859.00 | 884.00 | 654.00 | 546.00 |
| EPS (Recurring) | 2.98 | 3.57 | 2.22 | 2.52 | 2.63 | 2.71 | 2.27 | 3.56 |
| EPS (Basic, Before Extraordinaries) | 1.97 | 3.33 | 1.95 | 2.22 | 2.25 | 2.31 | 1.71 | 1.43 |
| EPS (Diluted) | 1.96 | 3.31 | 1.93 | 2.20 | 2.22 | 2.29 | 1.69 | 1.41 |
| EBITDA | 1,846.00 | 2,110.00 | 1,404.00 | 2,305.00 | 1,673.00 | 1,657.00 | 1,451.00 | 2,045.00 |
| Non-Operating Income (Expense) | 153.00 | 39.00 | 53.00 | 50.00 | 47.00 | 45.00 | -97.00 | -71.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 52.93 | 42.66 | 68.73 | 37.92 | 48.98 | 38.71 | 66.36 | 35.55 |
| Price To Earnings Ratio | 33.96 | 36.47 | 39.13 | 46.15 | 48.92 | 53.39 | 47.95 | 38.60 |
| Price To Sales Ratio | 4.03 | 4.70 | 5.03 | 5.41 | 5.86 | 6.42 | 6.20 | 6.15 |
| Gross Margin | 62.93 | 66.14 | 60.80 | 62.81 | 61.86 | 62.27 | 62.73 | 63.81 |
| Operating Margin | 23.79 | 27.53 | 18.34 | 27.74 | 22.52 | 22.60 | 20.10 | 27.67 |
| Net Margin | 11.55 | 19.37 | 12.38 | 11.84 | 14.18 | 14.68 | 11.15 | 8.48 |
| Shares Outstanding | 380.70 | 383.57 | 383.40 | 382.50 | 382.40 | 382.30 | 382.10 | 381.40 |
| Market Capitalization | 121,360.48 | 120,697.38 | 125,747.78 | 134,410.56 | 141,327.43 | 151,195.94 | 142,083.73 | 137,256.82 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 4,100.00 | 4,493.00 | 3,053.00 | 1,928.00 | 3,019.00 | 3,024.00 | 4,425.00 | 3,699.00 | 2,793.00 |
| Short Term Receivables | 4,039.00 | 3,987.00 | 3,765.00 | 3,565.00 | 3,022.00 | 2,701.00 | 2,893.00 | 2,332.00 | 2,198.00 |
| Inventories | 5,310.00 | 4,774.00 | 4,843.00 | 3,995.00 | 3,314.00 | 3,494.00 | 3,282.00 | 2,955.00 | 2,465.00 |
| Other Current Assets | 1,306.00 | 1,593.00 | 857.00 | 787.00 | 662.00 | 488.00 | 760.00 | 747.00 | 537.00 |
| Total Current Assets | 14,755.00 | 14,847.00 | 12,518.00 | 10,275.00 | 10,017.00 | 9,707.00 | 11,360.00 | 9,733.00 | 7,993.00 |
| Net Property, Plant & Equipment | 4,395.00 | 3,964.00 | 3,709.00 | 3,443.00 | 3,252.00 | 3,175.00 | 2,951.00 | 2,291.00 | 1,975.00 |
| Total Investments and Advances | 2.00 | 39.00 | 2.00 | 90.00 | 66.00 | 4.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 24,972.00 | 20,250.00 | 19,836.00 | 19,765.00 | 17,758.00 | 18,332.00 | 13,296.00 | 12,726.00 | 10,645.00 |
| Deferred Tax Assets | 1,098.00 | 1,742.00 | 1,670.00 | 1,410.00 | 1,760.00 | 1,530.00 | 1,575.00 | 1,678.00 | 283.00 |
| Other Assets | 2,622.00 | 2,129.00 | 2,177.00 | 1,901.00 | 1,778.00 | 1,582.00 | 985.00 | 801.00 | 1,301.00 |
| Total Assets | 47,844.00 | 42,971.00 | 39,912.00 | 36,884.00 | 34,631.00 | 34,330.00 | 30,167.00 | 27,229.00 | 22,197.00 |
| Short Term Debt Incl. Current Port. of LT Debt | 1,153.00 | 1,553.00 | 2,237.00 | 1,312.00 | 119.00 | 870.00 | 945.00 | 1,373.00 | 632.00 |
| Accounts Payable | 1,799.00 | 1,679.00 | 1,517.00 | 1,413.00 | 1,129.00 | 810.00 | 675.00 | 646.00 | 487.00 |
| Income Tax Payable | 418.00 | 539.00 | 391.00 | 292.00 | 192.00 | 207.00 | 171.00 | 158.00 | 143.00 |
| Other Current Liabilities | 4,424.00 | 3,845.00 | 3,776.00 | 3,286.00 | 3,109.00 | 3,154.00 | 2,609.00 | 2,630.00 | 2,223.00 |
| Total Current Liabilities | 7,794.00 | 7,616.00 | 7,921.00 | 6,303.00 | 4,549.00 | 5,041.00 | 4,400.00 | 4,807.00 | 3,485.00 |
| Long Term Debt | 15,207.00 | 12,567.00 | 11,257.00 | 12,214.00 | 12,782.00 | 13,555.00 | 10,532.00 | 8,486.00 | 6,590.00 |
| Provision for Risks Charges | 738.00 | 684.00 | 926.00 | 912.00 | 1,404.00 | 1,584.00 | 1,507.00 | 1,567.00 | 1,597.00 |
| Deferred Tax Liabilities | 137.00 | 82.00 | 63.00 | 67.00 | 68.00 | 117.00 | 108.00 | 54.00 | 47.00 |
| Other Liabilities | 1,548.00 | 1,388.00 | 1,152.00 | 772.00 | 951.00 | 949.00 | 813.00 | 585.00 | 498.00 |
| Total Liabilities | 25,424.00 | 22,337.00 | 21,319.00 | 20,268.00 | 19,754.00 | 21,246.00 | 17,360.00 | 15,499.00 | 12,217.00 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 22,420.00 | 20,634.00 | 18,593.00 | 16,616.00 | 14,877.00 | 13,084.00 | 12,807.00 | 11,730.00 | 9,966.00 |
| Total Shareholders Equity | 22,420.00 | 20,634.00 | 18,593.00 | 16,616.00 | 14,877.00 | 13,084.00 | 12,807.00 | 11,730.00 | 9,966.00 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00 |
| Total Equity | 22,420.00 | 20,634.00 | 18,593.00 | 16,616.00 | 14,877.00 | 13,084.00 | 12,807.00 | 11,730.00 | 9,980.00 |
| Total Liabilities & Stockholders Equity | 47,844.00 | 42,971.00 | 39,912.00 | 36,884.00 | 34,631.00 | 34,330.00 | 30,167.00 | 27,229.00 | 22,197.00 |
| Book Value Per Share | 58.61 | 54.10 | 48.92 | 43.88 | 39.41 | 34.79 | 34.20 | 31.33 | 26.62 |
| Tangible Book Value Per Share | -6.67 | 1.01 | -3.27 | -8.32 | -7.63 | -13.95 | -1.31 | -2.66 | -1.81 |
| Full-Time Employees | 56,000 | 53,000 | 52,000 | 51,000 | 46,000 | 43,000 | 40,000 | 36,000 | 33,000 |
| Price to Book Ratio | 5.17 | 6.81 | 6.35 | 5.62 | 6.79 | 7.04 | 6.14 | 5.00 | 5.55 |
| Return on Assets | 7.15 | 7.22 | 8.24 | 6.59 | 5.78 | 4.96 | 7.26 | 14.38 | 4.79 |
| Return on Equity | 15.08 | 15.26 | 17.98 | 14.97 | 14.26 | 12.35 | 16.98 | 32.75 | 10.45 |
| Return on Invested Capital | 8.63 | 9.01 | 10.60 | 8.18 | 7.21 | 6.00 | 8.92 | 17.58 | 6.16 |
| Quick Ratio | 1.21 | 1.32 | 0.97 | 1.00 | 1.47 | 1.23 | 1.84 | 1.41 | 1.59 |
| Current Ratio | 1.89 | 1.95 | 1.58 | 1.63 | 2.20 | 1.93 | 2.58 | 2.02 | 2.29 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 3,623.00 | 3,246.00 | 2,993.00 | 3,165.00 | 2,358.00 | 1,994.00 | 1,599.00 | 2,083.00 | 3,553.00 |
| Depreciation | 1,207.00 | 1,193.00 | 1,050.00 | 1,028.00 | 998.00 | 990.00 | 812.00 | 778.00 | 723.00 |
| Other Funds (Non Cash) | 570.00 | 586.00 | 1,252.00 | 259.00 | 435.00 | 804.00 | 422.00 | 386.00 | 158.00 |
| Funds from Operations | 5,767.00 | 5,417.00 | 4,925.00 | 4,246.00 | 3,849.00 | 3,551.00 | 2,881.00 | 3,373.00 | 2,852.00 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -321.00 | -373.00 | -683.00 | -535.00 | -1,225.00 | -288.00 | 396.00 | -1,182.00 | -242.00 |
| Income Taxes Payable | 37.00 | -145.00 | -116.00 | -4.00 | -238.00 | -98.00 | -16.00 | -105.00 | -156.00 |
| Cash from Operating Activities | 5,446.00 | 5,044.00 | 4,242.00 | 3,711.00 | 2,624.00 | 3,263.00 | 3,277.00 | 2,191.00 | 2,610.00 |
| Capital Expenditures | -873.00 | -761.00 | -755.00 | -575.00 | -588.00 | -525.00 | -487.00 | -649.00 | -572.00 |
| Net Assets From Acquisitions | -491.00 | -4,960.00 | -1,628.00 | -390.00 | -2,563.00 | -339.00 | -4,222.00 | -802.00 | -2,465.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 165.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Purchase or Sale of Investments | 81.00 | 750.00 | -660.00 | 2.00 | -9.00 | 6.00 | 7.00 | -5.00 | 168.00 |
| Purchase of Investments | 9.00 | 0.00 | -808.00 | -52.00 | -52.00 | -49.00 | -54.00 | -74.00 | -226.00 |
| Sale Or Maturity of Investments | 72.00 | 750.00 | 148.00 | 54.00 | 43.00 | 55.00 | 61.00 | 69.00 | 394.00 |
| Other Uses | -33.00 | -60.00 | 0.00 | 0.00 | 0.00 | -1.00 | 0.00 | 0.00 | -2.00 |
| Other Sources | 0.00 | 0.00 | 43.00 | 1.00 | 236.00 | 0.00 | 1.00 | 1.00 | 0.00 |
| Cash from Investing Activities | -1,316.00 | -4,866.00 | -3,000.00 | -962.00 | -2,924.00 | -859.00 | -4,701.00 | -1,455.00 | -2,871.00 |
| Cash Dividends Paid | -1,333.00 | -1,284.00 | -1,219.00 | -1,139.00 | -1,051.00 | -950.00 | -863.00 | -778.00 | -703.00 |
| Change in Capital Stock | -1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -307.00 | -300.00 |
| Repurchase of Common Pref Stock | -1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -307.00 | -300.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -1,504.00 | 1,579.00 | 940.00 | -277.00 | 472.00 | -1,153.00 | 989.00 | 1,293.00 | 2,456.00 |
| Change in Long Term Debt | -1,750.00 | 1,579.00 | 972.00 | -817.00 | 847.00 | -1,146.00 | 995.00 | 1,293.00 | 2,456.00 |
| Issuance of Long Term Debt | 0.00 | 2,979.00 | 3,011.00 | 1,241.00 | 1,500.00 | 5.00 | 3,292.00 | 2,642.00 | 3,126.00 |
| Reduction of Long Term Debt | -1,750.00 | -1,400.00 | -2,039.00 | -2,058.00 | -653.00 | -1,151.00 | -2,297.00 | -1,349.00 | -670.00 |
| Net Financing Active Other Cash Flow | -254.00 | -182.00 | -246.00 | -178.00 | -170.00 | -262.00 | -137.00 | -205.00 | -110.00 |
| Other Financing Activities Uses | -254.00 | -182.00 | -246.00 | -178.00 | -170.00 | -262.00 | -137.00 | -205.00 | -120.00 |
| Cash from Financing Activities | -4,091.00 | 113.00 | -525.00 | -1,594.00 | -749.00 | -2,365.00 | -11.00 | 3.00 | 1,343.00 |
| Exchange Rate Effect | -24.00 | 68.00 | -36.00 | -28.00 | -51.00 | -38.00 | 41.00 | -18.00 | -8.00 |
| Net Change in Cash | 15.00 | 359.00 | 681.00 | 1,127.00 | -1,100.00 | 1.00 | -1,394.00 | 721.00 | 1,074.00 |
| Free Cash Flow | 4,573.00 | 4,283.00 | 3,487.00 | 3,136.00 | 2,036.00 | 2,738.00 | 2,790.00 | 1,542.00 | 2,038.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 32.70 | 45.30 | 61.21 | 57.54 | 94.87 | 57.18 | 48.36 | 104.39 | 44.65 |
| Deferred Taxes & Investment Tax Credit | - | 392.00 | -370.00 | -206.00 | 58.00 | -237.00 | 48.00 | 126.00 | -1,582.00 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 3,271.00 | 3,476.00 | 2,965.00 | 4,100.00 | 3,343.00 | 2,464.00 |
| Short Term Receivables | 3,693.00 | 3,743.00 | 3,571.00 | 4,039.00 | 3,643.00 | 3,918.00 |
| Inventories | 5,747.00 | 5,521.00 | 5,419.00 | 5,310.00 | 5,370.00 | 5,289.00 |
| Other Current Assets | 1,472.00 | 1,678.00 | 1,383.00 | 1,306.00 | 1,355.00 | 1,332.00 |
| Total Current Assets | 14,183.00 | 14,418.00 | 13,338.00 | 14,755.00 | 13,711.00 | 13,003.00 |
| Net Property, Plant & Equipment | 4,572.00 | 4,479.00 | 4,416.00 | 4,395.00 | 4,273.00 | 4,253.00 |
| Total Investments and Advances | 67.00 | 81.00 | 82.00 | 2.00 | 44.00 | 3.00 |
| Intangible Assets | 24,868.00 | 25,326.00 | 24,704.00 | 24,972.00 | 25,101.00 | 25,145.00 |
| Deferred Tax Assets | 901.00 | 994.00 | 1,193.00 | 1,098.00 | 1,374.00 | 1,375.00 |
| Other Assets | 2,656.00 | 2,632.00 | 2,558.00 | 2,622.00 | 2,554.00 | 2,552.00 |
| Total Assets | 47,247.00 | 47,930.00 | 46,291.00 | 47,844.00 | 47,057.00 | 46,331.00 |
| Short Term Debt Incl. Current Port. of LT Debt | 914.00 | 909.00 | 660.00 | 1,153.00 | 1,911.00 | 1,910.00 |
| Accounts Payable | 1,634.00 | 1,663.00 | 1,592.00 | 1,799.00 | 1,498.00 | 1,442.00 |
| Income Tax Payable | 65.00 | 224.00 | 476.00 | 418.00 | 118.00 | 91.00 |
| Other Current Liabilities | 3,887.00 | 3,888.00 | 3,587.00 | 4,424.00 | 3,887.00 | 3,845.00 |
| Total Current Liabilities | 6,500.00 | 6,684.00 | 6,315.00 | 7,794.00 | 7,414.00 | 7,288.00 |
| Long Term Debt | 14,519.00 | 14,537.00 | 14,574.00 | 15,207.00 | 15,222.00 | 15,218.00 |
| Provision for Risks Charges | 413.00 | 406.00 | 403.00 | 738.00 | 400.00 | 395.00 |
| Deferred Tax Liabilities | - | - | - | 137.00 | - | - |
| Other Liabilities | 2,358.00 | 2,315.00 | 2,020.00 | 1,548.00 | 2,236.00 | 2,239.00 |
| Total Liabilities | 23,790.00 | 23,942.00 | 23,312.00 | 25,424.00 | 25,272.00 | 25,140.00 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 23,457.00 | 23,988.00 | 22,979.00 | 22,420.00 | 21,785.00 | 21,191.00 |
| Total Shareholders Equity | 23,457.00 | 23,988.00 | 22,979.00 | 22,420.00 | 21,785.00 | 21,191.00 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 23,457.00 | 23,988.00 | 22,979.00 | 22,420.00 | 21,785.00 | 21,191.00 |
| Total Liabilities & Stockholders Equity | 47,247.00 | 47,930.00 | 46,291.00 | 47,844.00 | 47,057.00 | 46,331.00 |
| Book Value Per Share | 61.62 | 62.54 | 59.93 | 58.61 | 56.97 | 55.43 |
| Tangible Book Value Per Share | -3.71 | -3.49 | -4.50 | -6.67 | -8.67 | -10.34 |
| Full-Time Employees | - | - | - | 56,000 | - | - |
| Price to Book Ratio | 5.17 | 5.25 | 5.61 | 6.17 | 6.67 | 7.22 |
| Return on Assets | 7.68 | 7.91 | 7.23 | 7.15 | 6.48 | 6.83 |
| Return on Equity | 16.02 | 16.51 | 15.20 | 15.08 | 14.04 | 14.25 |
| Return on Invested Capital | 1.98 | 3.31 | 1.98 | 2.26 | 2.32 | 2.43 |
| Quick Ratio | 1.30 | 1.33 | 1.25 | 1.21 | 1.13 | 1.06 |
| Current Ratio | 2.18 | 2.16 | 2.11 | 1.89 | 1.85 | 1.78 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 753.00 | 1,276.00 | 745.00 | 849.00 | 859.00 | 884.00 |
| Depreciation | 295.00 | 296.00 | 300.00 | 316.00 | 309.00 | 296.00 |
| Other Funds (Non Cash) | 360.00 | 55.00 | 87.00 | 68.00 | 196.00 | 169.00 |
| Funds from Operations | 1,500.00 | 1,734.00 | 1,099.00 | 1,434.00 | 1,379.00 | 1,511.00 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -39.00 | -473.00 | -518.00 | 709.00 | 161.00 | -400.00 |
| Income Taxes Payable | -137.00 | -300.00 | 42.00 | 432.00 | 33.00 | -659.00 |
| Cash from Operating Activities | 1,461.00 | 1,261.00 | 581.00 | 2,143.00 | 1,540.00 | 1,111.00 |
| Capital Expenditures | -237.00 | -202.00 | -166.00 | -268.00 | -187.00 | -183.00 |
| Net Assets From Acquisitions | -22.00 | -437.00 | -22.00 | -10.00 | -136.00 | -65.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 165.00 |
| Purchase or Sale of Investments | 85.00 | 2.00 | 2.00 | -8.00 | 3.00 | -1.00 |
| Purchase of Investments | -4.00 | -14.00 | -5.00 | 32.00 | -5.00 | -16.00 |
| Sale Or Maturity of Investments | 89.00 | 16.00 | 7.00 | -40.00 | 8.00 | 15.00 |
| Other Uses | -13.00 | -1.00 | 0.00 | -19.00 | -1.00 | -20.00 |
| Other Sources | 0.00 | -1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -187.00 | -639.00 | -185.00 | -305.00 | -321.00 | -104.00 |
| Cash Dividends Paid | -338.00 | -337.00 | -337.00 | -321.00 | -322.00 | -321.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | -1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -3.00 | 250.00 | -1,000.00 | -751.00 | -1.00 | -648.00 |
| Change in Long Term Debt | 0.00 | 0.00 | -1,000.00 | -750.00 | 0.00 | -650.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | -1,000.00 | -750.00 | 0.00 | -650.00 |
| Net Financing Active Other Cash Flow | -52.00 | -8.00 | -173.00 | -21.00 | -16.00 | -20.00 |
| Other Financing Activities Uses | -52.00 | -8.00 | -173.00 | -21.00 | -16.00 | -20.00 |
| Cash from Financing Activities | -1,393.00 | -95.00 | -1,510.00 | -1,093.00 | -339.00 | -989.00 |
| Exchange Rate Effect | -1.00 | -14.00 | -19.00 | 10.00 | 1.00 | 37.00 |
| Net Change in Cash | -120.00 | 513.00 | -1,133.00 | 755.00 | 881.00 | 55.00 |
| Free Cash Flow | 1,224.00 | 1,059.00 | 415.00 | 1,875.00 | 1,353.00 | 928.00 |
| Price to Free Cash Flow | 32.70 | 35.90 | 38.84 | 45.30 | 50.96 | 55.13 |
Revenue breakdown
| Endoscopy | 2024: 3.39B 2025: 3.81B |
|---|---|
| Hips | 2024: 1.70B 2025: 1.87B |
| Instruments | 2024: 2.83B 2025: 3.18B |
| Knees | 2024: 2.45B 2025: 2.66B |
| Medical | 2024: 3.85B 2025: 4.20B |
| Neuro Cranial | 2024: 2.14B 2025: 2.49B |
| Neurovascular | 2024: 1.31B 2025: 1.97B |
| Other Orthopaedics | 2024: 712.00M 2025: 815.00M |
| Spine | 2024: 707.00M 2025: 185.00M |
| Trauma and Extremities | 2024: 3.51B 2025: 3.95B |
| Asia Pacific | 2024: 2.02B 2025: 2.16B |
| EMEA | 2024: 2.90B 2025: 3.18B |
| Other foreign countries | 2024: 735.00M 2025: 765.00M |
| United States | 2024: 16.94B 2025: 19.01B |
| MedSurg and Neurotechnology | 2024: 13.52B 2025: 15.65B |
| Orthopaedics and Spine | 2024: 9.08B 2025: 9.47B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 1.86% | 6.7M | 358.3M | 2.72M |
| 2026-10-15 | 1.58% | 5.7M | 361.0M | 2.58M |
| 2026-09-30 | 1.59% | 5.7M | 361.0M | 2.62M |
| 2026-09-15 | 2.13% | 7.7M | 361.0M | 2.63M |
| 2026-08-31 | 2.12% | 7.6M | 360.9M | 2.46M |
| 2026-08-14 | 1.92% | 6.9M | 360.9M | 2.63M |
| 2026-07-31 | 2.31% | 8.3M | 360.6M | 2.80M |
| 2026-07-15 | 1.95% | 7.0M | 360.4M | 2.73M |
| 2026-06-30 | 1.92% | 6.9M | 360.4M | 2.59M |
| 2026-06-15 | 1.71% | 6.1M | 360.3M | 2.50M |
| 2026-05-29 | 1.73% | 6.2M | 360.4M | 2.46M |
| 2026-05-15 | 1.60% | 5.8M | 360.1M | 2.23M |
| 2026-04-30 | 1.23% | 4.4M | 359.6M | 2.08M |
| 2026-04-15 | 1.31% | 4.7M | 359.6M | 2.09M |
| 2026-03-31 | 1.23% | 4.4M | 359.4M | 2.12M |
| 2026-03-13 | 1.13% | 4.1M | 359.4M | 1.97M |
| 2026-02-27 | 1.19% | 4.3M | 359.4M | 1.85M |
| 2026-02-13 | 1.14% | 4.1M | 359.4M | 1.86M |
| 2026-01-30 | 1.15% | 4.1M | 358.8M | 1.81M |
| 2026-01-15 | 1.31% | 4.7M | 358.8M | 1.69M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 170 | 147.7 | 150.5 | 0.00 | 2.390 | 0.00 | 0.00 | 0.987 | -0.181 | 0.016 |
| call | 175 | 142.6 | 145.5 | 0.00 | 2.293 | 0.00 | 0.00 | 0.987 | -0.181 | 0.016 |
| call | 180 | 136.9 | 141 | 0.00 | 2.327 | 0.00 | 0.00 | 0.986 | -0.180 | 0.017 |
| call | 185 | 132.7 | 135.5 | 0.00 | 2.106 | 0.00 | 0.00 | 0.986 | -0.180 | 0.018 |
| call | 190 | 126.9 | 131 | 0.00 | 2.137 | 0.00 | 0.00 | 0.985 | -0.179 | 0.018 |
| call | 195 | 122.1 | 125.9 | 0.00 | 2.045 | 0.00 | 0.00 | 0.985 | -0.178 | 0.019 |
| call | 200 | 117.7 | 120.9 | 0.00 | 1.956 | 0.00 | 0.00 | 0.984 | -0.177 | 0.020 |
| call | 210 | 107.5 | 110.9 | 0.00 | 1.783 | 0.00 | 0.00 | 0.982 | -0.175 | 0.021 |
| call | 220 | 97.70 | 100.5 | 0.00 | 1.519 | 0.00 | 0.00 | 0.980 | -0.173 | 0.023 |
| call | 230 | 87.70 | 90.90 | 0.00 | 1.474 | 0.00 | 0.00 | 0.978 | -0.171 | 0.025 |
| call | 240 | 77.80 | 81.00 | 0.00 | 1.317 | 0.00 | 0.00 | 0.976 | -0.168 | 0.028 |
| call | 250 | 67.80 | 71.00 | 59.60 | 1.166 | 2.00 | 0.00 | 0.973 | -0.165 | 0.031 |
| call | 260 | 57.50 | 61.00 | 45.20 | 1.018 | 1.00 | 0.00 | 0.969 | -0.160 | 0.035 |
| call | 270 | 48.20 | 51.00 | 71.40 | 0.872 | 28.00 | 0.00 | 0.964 | -0.155 | 0.039 |
| call | 280 | 37.70 | 40.90 | 47.08 | 0.706 | 43.00 | 0.00 | 0.957 | -0.149 | 0.045 |
| call | 290 | 28.60 | 30.50 | 33.46 | 0.524 | 222 | 0.00 | 0.943 | -0.147 | 0.056 |
| call | 300 | 19.20 | 21.00 | 20.10 | 0.427 | 418 | 5.00 | 0.848 | -0.281 | 0.116 |
| call | 310 | 11.10 | 12.90 | 12.00 | 0.386 | 2,793 | 2.00 | 0.679 | -0.446 | 0.177 |
| call | 320 | 4.80 | 7.40 | 6.00 | 0.397 | 1,190 | 5.00 | 0.492 | -0.436 | 0.198 |
| call | 330 | 2.10 | 4.00 | 2.25 | 0.415 | 1,257 | 36.00 | 0.305 | -0.402 | 0.174 |
| call | 340 | 0.65 | 1.00 | 0.80 | 0.348 | 661 | 9.00 | 0.133 | -0.220 | 0.107 |
| call | 350 | 0.10 | 0.40 | 0.20 | 0.363 | 2,390 | 27.00 | 0.055 | -0.115 | 0.055 |
| call | 360 | 0.00 | 0.15 | 0.77 | 0.379 | 288 | 0.00 | 0.022 | -0.056 | 0.026 |
| call | 370 | 0.00 | 2.00 | 1.45 | 0.535 | 10.00 | 0.00 | 0.073 | -0.204 | 0.074 |
| call | 380 | 0.00 | 2.15 | 0.70 | 0.711 | 88.00 | 0.00 | 0.069 | -0.264 | 0.067 |
| call | 390 | 0.00 | 2.15 | 0.35 | 0.791 | 1.00 | 0.00 | 0.063 | -0.274 | 0.063 |
| call | 400 | 0.00 | 0.20 | 0.25 | 0.645 | 3.00 | 0.00 | 0.014 | -0.064 | 0.017 |
| call | 410 | 0.00 | 2.15 | 0.00 | 0.716 | 0.00 | 0.00 | 0.016 | -0.080 | 0.020 |
| call | 420 | 0.00 | 2.15 | 0.11 | 0.774 | 21.00 | 0.00 | 0.015 | -0.082 | 0.019 |
| put | 170 | 0.00 | 2.15 | 0.00 | 2.063 | 0.00 | 0.00 | -0.018 | -0.250 | 0.022 |
| put | 175 | 0.00 | 2.15 | 0.00 | 1.979 | 0.00 | 0.00 | -0.019 | -0.248 | 0.023 |
| put | 180 | 0.00 | 2.15 | 0.00 | 1.897 | 0.00 | 0.00 | -0.019 | -0.246 | 0.024 |
| put | 185 | 0.00 | 2.15 | 0.15 | 1.817 | 4.00 | 0.00 | -0.020 | -0.245 | 0.025 |
| put | 190 | 0.00 | 2.15 | 0.12 | 1.739 | 3.00 | 0.00 | -0.021 | -0.243 | 0.025 |
| put | 195 | 0.00 | 2.15 | 0.00 | 1.662 | 0.00 | 0.00 | -0.022 | -0.241 | 0.026 |
| put | 200 | 0.00 | 2.15 | 0.35 | 1.588 | 5.00 | 0.00 | -0.023 | -0.239 | 0.027 |
| put | 210 | 0.00 | 2.15 | 0.00 | 1.444 | 0.00 | 0.00 | -0.025 | -0.234 | 0.030 |
| put | 220 | 0.00 | 2.15 | 0.30 | 1.305 | 809 | 0.00 | -0.028 | -0.229 | 0.032 |
| put | 230 | 0.00 | 2.15 | 0.12 | 1.172 | 43.00 | 0.00 | -0.031 | -0.223 | 0.035 |
| put | 240 | 0.00 | 2.15 | 0.90 | 0.961 | 156 | 0.00 | -0.024 | -0.151 | 0.028 |
| put | 250 | 0.00 | 2.15 | 0.56 | 0.842 | 409 | 0.00 | -0.027 | -0.146 | 0.031 |
| put | 260 | 0.00 | 2.15 | 0.35 | 0.722 | 216 | 0.00 | -0.031 | -0.140 | 0.035 |
| put | 270 | 0.00 | 2.20 | 0.13 | 0.609 | 208 | 0.00 | -0.036 | -0.134 | 0.039 |
| put | 280 | 0.00 | 0.50 | 0.10 | 0.501 | 305 | 1.00 | -0.043 | -0.128 | 0.045 |
| put | 290 | 0.00 | 1.45 | 0.33 | 0.389 | 788 | 0.00 | -0.057 | -0.125 | 0.056 |
| put | 300 | 0.60 | 1.50 | 1.14 | 0.388 | 194 | 4.00 | -0.151 | -0.257 | 0.116 |
| put | 310 | 2.40 | 5.00 | 3.07 | 0.451 | 317 | 9.00 | -0.320 | -0.421 | 0.177 |
| put | 320 | 6.50 | 7.60 | 6.90 | 0.359 | 449 | 49.00 | -0.508 | -0.410 | 0.198 |
| put | 330 | 11.90 | 14.20 | 13.30 | 0.373 | 299 | 0.00 | -0.694 | -0.375 | 0.174 |
| put | 340 | 20.50 | 22.70 | 18.00 | 0.412 | 11.00 | 0.00 | -0.867 | -0.192 | 0.107 |
| put | 350 | 30.00 | 32.30 | 13.60 | 0.490 | 9.00 | 0.00 | -0.945 | -0.086 | 0.055 |
| put | 360 | 40.20 | 42.60 | 0.00 | 0.626 | 0.00 | 0.00 | -0.978 | -0.026 | 0.026 |
| put | 370 | 49.40 | 52.90 | 29.70 | 0.757 | 0.00 | 0.00 | -0.981 | -0.027 | 0.023 |
| put | 380 | 59.40 | 63.40 | 53.90 | 0.863 | 0.00 | 0.00 | -0.983 | -0.028 | 0.021 |
| put | 390 | 69.40 | 73.00 | 49.10 | 0.955 | 0.00 | 0.00 | -0.985 | -0.029 | 0.019 |
| put | 400 | 79.40 | 82.90 | 0.00 | 0.978 | 0.00 | 0.00 | -0.986 | -0.029 | 0.017 |
| put | 410 | 89.40 | 92.90 | 0.00 | 1.058 | 0.00 | 0.00 | -0.987 | -0.030 | 0.016 |
| put | 420 | 99.80 | 103 | 0.00 | 1.204 | 0.00 | 0.00 | -0.988 | -0.030 | 0.015 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-06 | SEC |
| 2026-11-09 | 8-K | Current report | 2026-11-03 | SEC |
| 2026-11-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-04 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | SEC | |
| 2026-10-30 | IRANNOTICE | Notice of Iran-related disclosure filed pursuant to Section 13(r)(3) of the Exchange Act | SEC | |
| 2026-10-30 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-10-29 | 8-K | Current report | 2026-10-29 | SEC |
| 2026-10-06 | 8-K | Current report | 2026-10-06 | SEC |
| 2026-09-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-24 | SEC |
| 2026-09-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-17 | SEC |
| 2026-09-08 | 3 | Initial statement of beneficial ownership of securities | 2026-09-01 | SEC |
| 2026-09-02 | 4 | Statement of changes in beneficial ownership of securities | 2019-06-26 | SEC |
| 2026-08-26 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-21 | SEC |
| 2026-08-20 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-18 | SEC |
| 2026-08-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-18 | SEC |
| 2026-08-18 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-17 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-01 | SEC |
| 2026-08-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-01 | SEC |
| 2026-08-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-01 | SEC |
| 2026-08-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-01 | SEC |
| 2026-07-31 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-07-30 | 8-K | Current report | 2026-07-30 | SEC |
| 2026-06-26 | 8-K | Current report | 2026-06-26 | SEC |
| 2026-06-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-01 | SEC |
| 2026-05-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-28 | SEC |
| 2026-05-28 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-05-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-26 | SEC |
| 2026-05-27 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-05-22 | SD | Specialized Disclosure Report | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 178.92M | 1 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 118.20M | 4 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 100.66M | 4 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 181.89M | 3 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 185.38M | 4 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 7.15% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.88% |
| JPMORGAN CHASE & CO | 4.50% |
| STATE STREET CORP | 4.05% |
| GREENLEAF TRUST | 3.95% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.11% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.13% |
| WELLINGTON MANAGEMENT GROUP LLP | 2.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.09% |
| MORGAN STANLEY | 1.55% |
Funds
| Fund | % owned |
|---|---|
| JPMorgan Ultra-Short Income ETF | 15.11% |
| PGIM Ultra Short Bond ETF | 7.82% |
| iShares Ultra Short Duration Bond Active ETF | 6.86% |
| Capital Group Central Corporate Bond Fund | 6.48% |
| VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND | 5.77% |
| VANGUARD SHORT-TERM INVESTMENT-GRADE FUND | 5.68% |
| PIMCO Investment Grade Credit Bond Fund | 5.50% |
| VANGUARD INSTITUTIONAL INTERMEDIATE-TERM BOND FUND | 5.22% |
| Dimensional Ultrashort Fixed Income ETF | 5.07% |
| VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND | 4.49% |
OakChart. SYK. Cached 15 minutes.